Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$245M |
| 2 |
KeyCorp
KEY
|
+$199M |
| 3 |
RTX Corp
RTX
|
+$183M |
| 4 |
EMC
EMC CORPORATION
EMC
|
+$170M |
| 5 |
Ralph Lauren
RL
|
+$167M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$245M |
| 2 |
US Bancorp
USB
|
+$216M |
| 3 |
Apple
AAPL
|
+$207M |
| 4 |
Visa
V
|
+$188M |
| 5 |
Bank of America
BAC
|
+$177M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 44.36% |
| 2 | Financials | 9.66% |
| 3 | Consumer Discretionary | 8.08% |
| 4 | Energy | 7.72% |
| 5 | Technology | 6.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4051
CALL
Sonoco
SON
$4.82B
| $358K | ﹤0.01% |
9,200
+5,300
| +136% | +$201K |
2013 Q2
1 quarter
|
|
|
MTOR
4052
CALL
DELISTED
MERITOR, Inc.
MTOR
| $358K | ﹤0.01% |
45,600
-8,300
| -15% | -$64.2K |
2013 Q2
1 quarter
|
|
|
CYT
4053
CALL
DELISTED
CYTEC INDS INC
CYT
| $358K | ﹤0.01% |
8,800
-7,600
| -46% | -$295K |
2013 Q2
1 quarter
|
|
|
ACCL
4054
DELISTED
Accelrys Inc
ACCL
| $358K | ﹤0.01% |
+36,334
| New | +$332K |
2013 Q3
0 quarters
|
|
|
ACOR
4055
CALL
DELISTED
Acorda Therapeutics
ACOR
| $357K | ﹤0.01% |
87
-11
| -11% | -$47.4K |
2013 Q2
1 quarter
|
|
|
IMPV
4056
DELISTED
Imperva, Inc.
IMPV
| $357K | ﹤0.01% |
+8,495
| New | +$405K |
2013 Q3
0 quarters
|
|
|
SKUL
4057
PUT
DELISTED
SKULLCANDY INC
SKUL
| $357K | ﹤0.01% |
57,800
-25,000
| -30% | -$140K |
2013 Q2
1 quarter
|
|
4058
CALL
CBRE Group
CBRE
$37.5B
| $356K | ﹤0.01% |
15,400
-4,500
| -23% | -$104K |
2013 Q2
1 quarter
|
|
|
RSTI
4059
DELISTED
Rofin-Sinar Technologies Inc
RSTI
| $356K | ﹤0.01% |
+14,707
| New | +$349K |
2013 Q3
0 quarters
|
|
|
OSIR
4060
PUT
DELISTED
Osiris Therapeutics, Inc. Common Stock
OSIR
| $356K | ﹤0.01% |
21,400
+14,500
| +210% | +$214K |
2013 Q2
1 quarter
|
|
|
AAWW
4061
PUT
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
| $355K | ﹤0.01% |
7,700
-19,700
| -72% | -$891K |
2013 Q2
1 quarter
|
|
4062
Acadia Healthcare
ACHC
$2.61B
| $354K | ﹤0.01% |
+8,980
| New | +$333K |
2013 Q3
0 quarters
|
|
4063
Cato Corp
CATO
$47.8M
| $354K | ﹤0.01% |
12,651
+2,047
| +19% | +$55.8K |
2013 Q2
1 quarter
|
|
4064
PUT
Carpenter Technology
CRS
$19.3B
| $354K | ﹤0.01% |
6,100
-2,600
| -30% | -$139K |
2013 Q2
1 quarter
|
|
4065
PUT
Diana Shipping
DSX
$356M
| $354K | ﹤0.01% |
41,909
-13,588
| -24% | -$104K |
2013 Q2
1 quarter
|
|
4066
PUT
IMAX
IMAX
$2.89B
| $354K | ﹤0.01% |
11,700
-26,900
| -70% | -$724K |
2013 Q2
1 quarter
|
|
|
MGLN
4067
PUT
DELISTED
Magellan Health Services, Inc.
MGLN
| $354K | ﹤0.01% |
5,900
-3,000
| -34% | -$174K |
2013 Q2
1 quarter
|
|
|
EOCC
4068
DELISTED
Enel Generacion Chile S.A.
EOCC
| $354K | ﹤0.01% |
12,187
-26,977
| -69% | -$774K |
2013 Q2
1 quarter
|
|
|
CNW
4069
CALL
DELISTED
CON-WAY INC.
CNW
| $353K | ﹤0.01% |
8,200
-2,800
| -25% | -$119K |
2013 Q2
1 quarter
|
|
|
ELP
4070
DELISTED
Companhia Paranaense de Energia (COPEL)
ELP
| $352K | ﹤0.01% |
62,935
-456,755
| -88% | -$2.36M |
2013 Q2
1 quarter
|
|
|
GES
4071
DELISTED
Guess Inc
GES
| $352K | ﹤0.01% |
+11,816
| New | +$369K |
2013 Q3
0 quarters
|
|
4072
Quantum Corp
QMCO
$1.36B
| $352K | ﹤0.01% |
1,591
+774
| +95% | +$189K |
2013 Q2
1 quarter
|
|
|
VOCS
4073
DELISTED
VOCUS INC
VOCS
| $352K | ﹤0.01% |
37,814
-101,629
| -73% | -$1.03M |
2013 Q2
1 quarter
|
|
4074
Ennis
EBF
$571M
| $351K | ﹤0.01% |
19,461
-13,644
| -41% | -$249K |
2013 Q2
1 quarter
|
|
|
MODV
4075
DELISTED
ModivCare
MODV
| $351K | ﹤0.01% |
12,232
-25,136
| -67% | -$707K |
2013 Q2
1 quarter
|
|
Similar funds
Citadel Advisors's Q3 2013 Portfolio in Review
As of Q3 2013, Citadel Advisors held 7,215 positions worth $65.7B, up 13% from $58.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Citadel Advisors withdrew a net $4.68B in Q3 2013, closing 505 positions and reducing 3,074 holdings. Its most notable exit was NEWS CORPORATION CL-A, an estimated $166M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 44% of assets, up from 41% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Citadel Advisors opened a new position in ELAN CORP ADS(RP1 ORD4IRISH PN worth $100M.
- Citadel Advisors's largest Q3 2013 buy was ELAN CORP ADS(RP1 ORD4IRISH PN: 6,448,014 shares worth $100M.
- Citadel Advisors added most to Philip Morris in Q3 2013, an estimated $245M increase.
- Citadel Advisors's biggest Q3 2013 reduction was Pfizer, cutting an estimated $245M.
- Citadel Advisors fully exited NEWS CORPORATION CL-A in Q3 2013, selling an estimated $166M.
- Citadel Advisors's ten largest holdings make up 12% of its $65.7B portfolio in Q3 2013.
- Citadel Advisors opened 734 new positions and closed 505 in Q3 2013.
- Citadel Advisors's portfolio value rose 13% quarter-over-quarter to $65.7B.
Based on Citadel Advisors's 13F filing for Q3 2013, filed 14 Nov 2013.